3 hrs ago
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
The heartburn holiday: Don't let acid reflux ruin your Thanksgiving
Thanksgiving barrels toward us almost as fast as the heartburn that follows. So, of course, medical folks concerned with gastrointestinal issues have designated Nov. 24-30 GERD Awareness Week, GERD being short for gastroesophageal reflux disease, a condition believed to affect 10 percent to 20 percent of us.
Safe treatments for GERD are available
Gastroesophageal reflux disease is a common problem you see and hear about every day, from advertisements on TV to medications in the store that claim to treat it.
Health | Healthy Living: GERD Awareness Week- November 24-30
Thanksgiving is a time for family and friends to gather, give thanks and enjoy a delicious and abundant feast.
Family Health Matters: Don't invite Gerd at your Thanksgiving table
Unfortunately for many people, the epicurean excess associated with Thanksgiving comes with an unpleasant side dish: heartburn, caused by gastroesophageal reflux.
Q&A: Evaluating The Effectiveness Of Stretta As A Treatment For GERD
Stretta is a minimally invasive, outpatient procedure that dramatically reduces GERD symptoms and offers an alternative to anti-reflux surgery in so-called "refractory" GERD sufferers, or those who do not get adequate relief from medications used to treat the symptoms of GERD.
Long-term follow up in patients with GERD
A study in this month's issue of the Scandanavian Journal of Gastroenterology evaluated long-term results of GERD treatments with regard to reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome.
First Generic Versions of Delayed-Release Rabeprazole (AcipHex) Approved to Treat GERD
The FDA has approved the first generic versions of rabeprazole sodium delayed-release tablets , used to treat gastroesophageal reflux disease in adults and adolescents .
Eisai Announces Availability of Aciphex Sprinkle
Eisai Inc. announced today that ACIPHEX Sprinkle Delayed-Release Capsules 5mg and 10mg will be available to eligible patients by prescription in the United States by November 8, 2013.
Lupin launches generic GERD drug in the US market
Inc's Aciphex delayed-release tablets, used to treat gastroesophageal reflux disease, in the US market.